FDA Halts Acceptance Of Chinese Lab Data Due To Accuracy Issues

The FDA has stopped accepting data from two Chinese labs due to accuracy issues. Mid-Link and SDWH have been flagged for potentially falsified results and other misconduct. This decision, which follows months of discussions and warnings, emphasizes the FDA's commitment to ensuring data integrity in medical device submissions.

(Shutterstock)

The US Food and Drug Administration will no longer accept data from two Chinese product testing labs due to ongoing accuracy concerns, the agency announced on 22 May.

The labs, Mid-Link Technology Testing Co. in Tianjin and Sanitation & Environment Technology Institute of Soochow University (SDWH) in Suzhou,...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Compliance

More from Policy & Regulation